Huntington’s gene therapy research has reached a turning point, expert says
Despite unanticipated regulatory hurdles following promising clinical results with a novel investigational treatment for Huntington’s Disease, the significance of the…
Despite unanticipated regulatory hurdles following promising clinical results with a novel investigational treatment for Huntington’s Disease, the significance of the…
The Netherlands is falling behind other European countries in providing access to advanced therapy medicinal products (ATMPs) according to Peter…
Cell therapies have gained steam in oncology since Novartis’s Kymriah (tisagenlecleucel) became the first chimeric antigen receptor (CAR)-T cell therapy…
A notable growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM;…
Solid Biosciences is positioning itself for a potentially “transformative” year as it builds on its 2025 success and centres its…
Panels at the Alliance for Regenerative Medicine’s Industry Briefing highlighted how CGTs are expanding beyond rare disease into broader indications,…
As confidence grows for innovative in vivo strategies, some investors are saying they could be the future of the cell…
Later this month, experts from the pharmaceutical and biotechnology industry and patient advocacy space will gather in Munich, Germany, to…
Metagenomi will slash a quarter of its workforce and switch up its CEO as part of efforts to extend its…
The path to approval for uniQure’s gene therapy candidate for Huntington’s disease is in doubt as the US Food and…